NDC 44206-417

Carimune Nanofiltered

Human Immunoglobulin G

Carimune Nanofiltered is a Intravenous Injection, Powder, Lyophilized, For Solution in the Plasma Derivative category. It is labeled and distributed by Csl Behring Ag. The primary component is Human Immunoglobulin G.

Product ID44206-417_6d78337d-6fba-4156-a522-1c03c9181489
NDC44206-417
Product TypePlasma Derivative
Proprietary NameCarimune Nanofiltered
Generic NameHuman Immunoglobulin G
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2009-02-10
Marketing End Date2021-05-31
Marketing CategoryBLA / BLA
Application NumberBLA102367
Labeler NameCSL Behring AG
Substance NameHUMAN IMMUNOGLOBULIN G
Active Ingredient Strength6 g/1
Pharm ClassesHuman Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS]
NDC Exclude FlagN

Packaging

NDC 44206-417-06

1 VIAL, SINGLE-USE in 1 CARTON (44206-417-06) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-417-91)
Marketing Start Date2009-02-10
Marketing End Date2021-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 44206-417-06 [44206041706]

Carimune Nanofiltered INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA102367
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2009-02-10
Marketing End Date2021-05-31

NDC 44206-417-91 [44206041791]

Carimune Nanofiltered INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA102367
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2012-11-09
Marketing End Date2021-05-31

Drug Details

Active Ingredients

IngredientStrength
HUMAN IMMUNOGLOBULIN G6 g/1

Pharmacological Class

  • Human Immunoglobulin G [EPC]
  • Passively Acquired Immunity [PE]
  • Antigen Neutralization [MoA]
  • Immunoglobulins [CS]

NDC Crossover Matching brand name "Carimune Nanofiltered" or generic name "Human Immunoglobulin G"

NDCBrand NameGeneric Name
44206-417CarimuneHUMAN IMMUNOGLOBULIN G
44206-418CarimuneHUMAN IMMUNOGLOBULIN G
44206-451HizentraHUMAN IMMUNOGLOBULIN G
44206-452HizentraHUMAN IMMUNOGLOBULIN G
44206-454HizentraHUMAN IMMUNOGLOBULIN G
44206-455HizentraHUMAN IMMUNOGLOBULIN G
44206-456HizentraHUMAN IMMUNOGLOBULIN G
44206-436PrivigenHuman Immunoglobulin G
44206-437PrivigenHuman Immunoglobulin G
44206-438PrivigenHuman Immunoglobulin G
44206-439PrivigenHuman Immunoglobulin G

Trademark Results [Carimune]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CARIMUNE
CARIMUNE
76345581 2782715 Live/Registered
CSL BEHRING AG
2001-12-06
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.